Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Assessing incidence and economic burden of genital warts with data from a US commercially insured population
Current Medical Research and Opinion, 08/13/09
Hoy T et al. – Genital warts represent a significant health and cost burden in the US. Adoption of novel healthcare technologies such as vaccines along with traditional interventions such as physician education of signs and symptoms, condom use and abstinence or limiting number of sexual partners may significantly help reduce the burden of genital warts.
Related Articles
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Relevance Score: 69%
U.S. OKs Merck shot to prevent male genital warts
Reuters, 10/19/09
Relevance Score: 68%
Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women
Sexually Transmitted Infections, 10/22/09
Relevance Score: 66%
The psychological impact caused by genital warts: has the Department of Health's choice of vaccination missed the opportunity to prevent such morbidity
International Journal of STD & AIDS, 10/13/09
Relevance Score: 66%
ACIP Supports 'Permissive Use,' But Not Routine Use, of Gardasil in Males
American Family Physician, 10/29/09
Relevance Score: 64%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09
Myxedema Coma Associated with Combination Aripiprazole and Sertraline Therapy
Annals of Pharmacotherapy, 12/03/09
Factors Associated with Multiple Medication Use in Different Age Groups
Annals of Pharmacotherapy, 12/03/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
PharmacoEconomics, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


